Scott brings a unique perspective to funding and growing healthcare companies from his broad capital markets experience, where he was able to leverage his academic background in life sciences and computer engineering. His interest in biotechnology was sparked by the Human Genome Project and his studies in biomedical computing. Prior to Antibe, he was an investment banking professional with Bloom Burton & Co., a leading healthcare-focused investment dealer and advisory firm. Scott was also an Equity Research Analyst at Cantor Fitzgerald Canada where his coverage included Specialty Pharma. Scott holds a Bachelor of Biomedical Computing from Queen’s University, a Master of Computer Engineering from the University of Toronto and is a CFA charterholder.
Keynote
Listed Company
Healthcare, Biotech
Scott Stewart
IBI Group
Scott Stewart is Chief Executive Officer of IBI Group, responsible for providing executive leadership with a particular focus on operational management and execution. He became CEO in August 2013, and has been with the firm since 1983, initially as a transportation engineer and planner. He led the firm’s tech pivot and development of its Intelligence practice, turning it into a worldwide business with projects and offices globally.
Mr. Stewart has been active in several professional organizations including Board seats with the Transportation Association of Canada (TAC) and ITS Canada where he fulfilled various roles, including chair. Mr. Stewart has a Bachelor of Science (Civil Engineering) from the University of Waterloo.
Keynote
Listed Company
Engineering, Infrastructure, Technology
Grant Connelly
Neupath
Mr. Connelly joined NeuPath in July 2018 and was promoted to CEO in February 2019. Prior to joining NeuPath, Mr. Connelly’s previous roles were CEO of VroomHealth Inc; and CFO of Appletree Medical Group Inc., a company that operates over 30 primary care clinics. Mr. Connelly has played a leadership role in M&A transactions valued at over $200 million. Mr. Connelly holds an MBA from the Schulich School of Business at York University.
Mr. Lemieux joined NeuPath as CFO in April 2019. Mr. Lemieux has more than 17 years of experience in public companies including over 8 years as a Chief Financial Officer and 13 years in the health care industry. Mr. Lemieux has been involved with or led numerous debt and equity financings, licensing and M&A transactions valued at over $400 million. Mr. Lemieux is a Chartered Professional Accountant.
Keynote
Listed Company
Healthcare
Jeremy Sobotta
Perimeter
Mr. Sobotta brings to Perimeter a diverse background in the medical devices industry, and, to date, has been a part of the deployment of over $4 billion in capital in acquisitions. Previously, Mr. Sobotta was the controller for the orthopaedics division of Smith and Nephew. From 2008 to 2019, he held roles of increasing responsibility at Stryker including internal audit, finance transformation, commercial excellence, financial planning and analysis, and ultimately led finance for their surgical business unit. Mr. Sobotta has lived and worked in North America, Europe, and Africa supporting commercial organizations across a wide range of medical technology including capital equipment, robotics, and implants.
Keynote
Listed Company
Medtech
Jesse McConnell
Rubicon Organics
Jesse has a proven track record from his time as Co-Founder of Whistler Medical Marijuana Company (“WMMC”) – the first certified organic, federally-licensed cannabis growing facility in Canada – which was sold to Aurora for $175 million in January 2019. With nearly two decades of experience in the cannabis industry, Jesse has an unparallel network of relationships in the industry and has been involved in the design and licensure of multiple facilities across Canada and the United States. Jesse’s industry experience also includes the development of proprietary, innovative growth techniques to produce high-quality, certified organic, cannabis crops. Jesse has a B.A. (Hons) in Economics and a M.A. in Philosophy.
Keynote
Listed Company
Wellness, Cannabis
Corporates
Company backgrounds and useful links.
Antibe Therapeutics
Scott Curtis
Antibe Therapeutics is a clinical-stage biotechnology company developing next-generation, safer medicines for pain and inflammation. The company’s hydrogen sulfide drug platform is designed to overcome the gastrointestinal ulcers and bleeding associated with NSAIDs, a class of drugs used by most North Americans and by billions of people globally. Antibe’s lead drug candidate, otenaproxesul, is entering Phase III for osteoarthritis pain with robust clinical results for both gastrointestinal safety and efficacy. Additional assets under development include a safer non-opioid for peri-operative pain, and a safer alternative to low-dose aspirin.
Keynote
Listed Company
Healthcare, Biotech
IBI Group
Scott Stewart
IBI Group Inc. (TSX:IBG) is a technology-driven design firm with global architecture, engineering, planning, and technology expertise spanning over 60 offices and 2,700 professionals around the world. For nearly 50 years, its dedicated professionals have helped clients create livable, sustainable, and advanced urban environments. IBI Group believes that cities thrive when designed with intelligent systems, sustainable buildings, efficient infrastructure, and a human touch.
Keynote
Listed Company
Engineering, Infrastructure, Technology
Neupath
Grant Connelly
NeuPath is Canada’s largest provider of chronic pain management services that operates under two leading brands in Ontario: CPM - Centres for Pain Management and InMedic Creative Medicine. NeuPath has 12 locations across Ontario with more than 100 health care providers that provide care to over 11,000 patients annually. NeuPath offers a comprehensive chronic pain assessment and multi-modal treatment plan based on recommendations by a group of trained physicians to help patients manage their chronic pain and optimize their quality of life. In addition to chronic pain management clinics, NeuPath provides workplace health services and independent medical assessments to disability insurers through its subsidiary, CompreMed Canada Inc. (“CompreMed”). The single, largest cost of chronic pain is lost productivity due to job loss and sick days.
Keynote
Listed Company
Healthcare
Perimeter
Jeremy Sobotta
Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address unmet medical needs, with the goal of improving long-term outcomes for patients and lowering costs to the healthcare system. Perimeter's optical tissue imaging console is cleared by FDA as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization, with image review manipulation software for identifying and annotating regions of interest. In addition, Perimeter is developing advanced artificial intelligence/machine learning image assessment tools intended to increase the efficiency of review. Perimeter's ticker symbol "PINK" is a reference to the pink ribbons used to raise awareness about Breast Cancer, reflecting the company's dedication to helping surgeons, radiologists and pathologists use Perimeter's imaging technology and AI in the fight against breast cancer.
Keynote
Listed Company
Medtech
Rubicon Organics
Jesse McConnell
Rubicon Organics Inc. is becoming the global brand leader in organic cannabis products. Through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer, the Company cultivates and sells organic certified, sustainably grown, super-premium cannabis from its state-of-the-art hybrid greenhouse located in Delta, BC, Canada. Rubicon Organics is focused on achieving industry leading profitability through the development of brands and cannabis 2.0 products, including its flagship super-premium brand Simply BareTM Organic.
